Syndax Pharmaceuticals Inc (SNDX) vs. Its Peers: A Comparison
Additionally, the 36-month beta value for SNDX is 0.92. There are mixed opinions on the stock, with 4 analysts rating it as a “buy,” 4
Additionally, the 36-month beta value for SNDX is 0.92. There are mixed opinions on the stock, with 4 analysts rating it as a “buy,” 4
In the past week, SNDX stock has gone up by 9.29%, with a monthly gain of 10.50% and a quarterly plunge of -13.82%. The volatility
The stock of Syndax Pharmaceuticals Inc (NASDAQ: SNDX) has decreased by -0.66 when compared to last closing price of 18.32. Despite this, the company has
Additionally, the 36-month beta value for SNDX is 0.91. There are mixed opinions on the stock, with 4 analysts rating it as a “buy,” 4
© 2024, Powered by Smart TechOne
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.